Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Selcia completes drug discovery project with ExonHit Therapeutics using fragment screening technology

Selcia completes drug discovery project with ExonHit Therapeutics using fragment screening technology

Study: Storytelling program improves communication skills, positive affect in persons with dementia

Study: Storytelling program improves communication skills, positive affect in persons with dementia

Nation wide aged care deficits surface in report

Nation wide aged care deficits surface in report

Roundup: In Ariz., Senate panel takes steps to end Medicaid; Mass. Gov. starts sales pitch for payment reform

Roundup: In Ariz., Senate panel takes steps to end Medicaid; Mass. Gov. starts sales pitch for payment reform

Researchers to share information on delirium at ADS conference

Researchers to share information on delirium at ADS conference

New research: Alzheimer's disease may be easily misdiagnosed in elder people

New research: Alzheimer's disease may be easily misdiagnosed in elder people

ISCTM 7th annual meeting to discuss drug development based on amyloid hypothesis of Alzheimer's disease

ISCTM 7th annual meeting to discuss drug development based on amyloid hypothesis of Alzheimer's disease

Positive results from Harbor BioSciences' Triolex initial preclinical study for treatment of PD

Positive results from Harbor BioSciences' Triolex initial preclinical study for treatment of PD

Speaking more languages may lower risk of developing memory problems

Speaking more languages may lower risk of developing memory problems

Simple on-road tests can help determine safe driving after stroke

Simple on-road tests can help determine safe driving after stroke

Middle-age people with cardiovascular issues may have increased risk of developing early memory problems

Middle-age people with cardiovascular issues may have increased risk of developing early memory problems

Swedish scientist: Social, physical and mental activities can minimize risk of dementia

Swedish scientist: Social, physical and mental activities can minimize risk of dementia

Amphetamines appear to increase risk of developing Parkinson's disease: New research

Amphetamines appear to increase risk of developing Parkinson's disease: New research

Language skills promote cognitive function and delay Alzheimer’s: Study

Language skills promote cognitive function and delay Alzheimer’s: Study

New book on staying fit after 60 by 77-year-old man

New book on staying fit after 60 by 77-year-old man

How Huntington's disease proteins move from cell to cell

How Huntington's disease proteins move from cell to cell

Bilingualism enhances multi-tasking skills

Bilingualism enhances multi-tasking skills

DiaGenic fourth quarter operating revenue increases to NOK 1,078 thousand

DiaGenic fourth quarter operating revenue increases to NOK 1,078 thousand

Scientists discover axons can send signals to cell body

Scientists discover axons can send signals to cell body

Researchers identify normal movement mechanisms of PrPC in brain

Researchers identify normal movement mechanisms of PrPC in brain

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.